Needham & Company Starts Tetralogic Pharmaceuticals (TLOG) at Buy

January 6, 2014 7:24 AM EST Send to a Friend
Needham & Company initiates coverage on Tetralogic Pharmaceuticals (NASDAQ: TLOG) with a Buy. PT $16.00.

Analyst Chad Messer, Ph.D ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login